Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-02-09 Patel Sanj K Chairman & CEO Purchase · Series C Preferred Shares +63,922 $15.64 $1000K 63,922
2018-02-09 Beetham Thomas W. Chief Legal Officer Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392
2018-02-09 BOESS CARSTEN 10% owner Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392
2018-02-09 Mahoney Stephen F. President & COO Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392
2018-02-09 Heberlig Chris Exec VP & CFO Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392

Page 81 of 81 · 1,605 trades